Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis

Frontiers in Neuroendocrinology

Volumn 35, Issue 2, 2014, Pages 197-220

  Handa, Robert J ^a   Weiser, Michael J ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b DSM NUTRITIONAL PRODUCTS   (United States)

Author keywords

Androgen receptor; CRF; Dihydrotestosterone; Estradiol; Estrogen receptor; Glucocorticoid; HPA; HPG; Sex difference; Testosterone

Indexed keywords

4 AMINOBUTYRIC ACID; ANDROGEN RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLUCAGON LIKE PEPTIDE 1; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; NORADRENALIN; OXYTOCIN; SEX HORMONE; SOMATOSTATIN; THYROTROPIN; VASOPRESSIN;

ANXIETY DISORDER; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; CORTICOTROPIN RELEASE; DEPRESSION; ENVIRONMENTAL STRESS; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NEUROENDOCRINE SYSTEM; NEUROSECRETORY CELL; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STEROID METABOLISM; ANIMAL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PHYSIOLOGICAL STRESS; PHYSIOLOGY;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; GONADAL STEROID HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, ESTROGEN; STRESS, PHYSIOLOGICAL;

EID: 84896126020     PISSN: 00913022     EISSN: 10956808     Source Type: Journal    
DOI: 10.1016/j.yfrne.2013.11.001     Document Type: Review

References (482)

1. Abe K., Critchlow V. Delayed feedback inhibition of stress-induced activation of pituitary-adrenal function: effects of varying dose, rate and duration of corticosterone administration and of telencephalon removal. Neuroendocrinology 1980, 31:349-354.
2. Abel K., Majzoub J.A. Molecular biology of the HPA axis. Handbook of Stress and the Brain 2005, 79-94. Elsevier. T. Steckler, N.H. Kalin, J.M. Reul (Eds.).
3. Abraham I.M., Todman M.G., Korach K.S., Herbison A.E. Critical in vivo roles for classical estrogen receptors in rapid estrogen actions on intracellular signaling in mouse brain. Endocrinology 2004, 145:3055-3061.
4. Adan R.A., Cox J.J., Beischlag T.V., Burbach J.P. A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol. Endocrinol. 1993, 7:47-57.
5. Adler A., Vescovo P., Robinson J.K., Kritzer M.F. Gonadectomy in adult life increases tyrosine hydroxylase immunoreactivity in the prefrontal cortex and decreases open field activity in male rats. Neuroscience 1999, 89:939-954.
6. Aguilera G., Nikodemova M., Wynn P.C., Catt K.J. Corticotropin releasing hormone receptors: two decades later. Peptides 2004, 25:319-329.
7. Ahima R.S., Harlan R.E. Charting of type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system. Neuroscience 1990, 39:579-604.
8. Ahima R., Krozowski Z., Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat CNS: distribution and regulation by corticosteroids. J. Comp. Neurol. 1991, 313:522-538.
9. Akana S.F., Cascio C.S., Du J.Z., Levin N., Dallman M.F. Reset of feedback in the adrenocortical system: an apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening. Endocrinology 1986, 119:2325-2332.
10. Allen B.D., Sutanto W., Jones M.T. A correlative study of RU38486 biopotency and competition with [3H]dexamethasone for receptors in the rat central nervous system. J. Steroid Biochem. 1988, 30:411-415.
11. Almeida O.F., Conde G.L., Crochemore C., Demeneix B.A., Fischer D., Hassan A.H., Meyer M., Holsboer F., Michaelidis T.M. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 2000, 14:779-790.
12. Almeida O.P., Waterreus A., Spry N., Flicker L., Martins R.N. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 2004, 29:1071-1081.
13. Amore M. Partial androgen deficiency and neuropsychiatric symptoms in aging men. J. Endocrinol. Invest. 2005, 28:49-54.
14. Amoss M., Burgus R., Blackwell R., Vale W., Fellows R., Guillemin R. Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin. Biochem. Biophys. Res. Commun. 1971, 44:205-210.
15. Angold A., Worthman C.W. Puberty onset of gender differences in rates of depression: a developmental, epidemiologic and neuroendocrine perspective. J. Affect. Disord. 1993, 29:145-158.
16. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 1986, 7:351-378.
17. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 1999, 160:1-12.
18. Armstrong W.E., Warach S., Hatton G.I., McNeill T.H. Subnuclei in the rat hypothalamic paraventricular nucleus: a cytoarchitectural, horseradish peroxidase and immunocytochemical analysis. Neuroscience 1980, 5:1931-1958.
19. Aronsson M., Fuxe K., Dong Y., Agnati L.F., Okret S., Gustafsson J.A. Localization of glucocorticoid receptor mRNA in the male rat brain by in situ hybridization. Proc. Natl. Acad. Sci. USA 1988, 85:9331-9335.
20. Axelrod J., Reisine T.D. Stress hormones: their interaction and regulation. Science 1984, 224:452-459.
21. Azcoitia I., Sierra A., Garcia-Segura L.M. Localization of estrogen receptor beta-immunoreactivity in astrocytes of the adult rat brain. Glia 1999, 26:260-267.
22. Babb J.A., Masini C.V., Day H.E., Campeau S. Sex differences in activated corticotropin-releasing factor neurons within stress-related neurocircuitry and hypothalamic-pituitary-adrenocortical axis hormones following restraint in rats. Neuroscience 2013, 234:40-52.
23. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
24. Bargmann W. Uber die neurosekretorische verknupfung von hypothlamus und neurohypophyse. Z. Zellforsch. Mikrosk. Anat. 1949, 34:610-634.
25. Bargmann W., Scharrer E. The site of origin of the hormones of the posterior pituitary. Am. Sci. 1951, 39:255-259.
26. Becker H., Grabosch E., Hoffmann C., Voigt K.D. Metabolism and mode of action of androgens in target tissues of male rats. 3. Metabolism of 5 alpha-androstane-3,17-dione, of 5 alpha-androstane-3 beta,17 beta-diol and of 5 alpha-androstane-3 beta,17 beta-diol in target organs and peripheral tissues. Acta Endocrinol. (Copenh) 1973, 73:407-416.
27. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog. Neurobiol. 1995, 46:575-605.
28. Belelli D., Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 2005, 6:565-575.
29. Bellocchio L., Cervino C., Pasquali R., Pagotto U. The endocannabinoid system and energy metabolism. J. Neuroendocrinol. 2008, 20:850-857.
30. Biag J., Huang Y., Gou L., Hintiryan H., Askarinam A., Hahn J.D., Toga A.W., Dong H.W. Cyto- and chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J. Comp. Neurol. 2012, 520:6-33.
31. Bilezikjian L.M., Vale W.W. Regulation of ACTH secretion from corticotrophs: the interaction of vasopressin and CRF. Ann. N. Y. Acad. Sci. 1987, 512:85-96.
32. Bingaman E.W., Magnuson D.J., Gray T.S., Handa R.J. Androgen inhibits the increases in hypothalamic corticotropin-releasing hormone (CRH) and CRH-immunoreactivity following gonadectomy. Neuroendocrinology 1994, 59:228-234.
33. Bingham B., Williamson M., Viau V. Androgen and estrogen receptor-beta distribution within spinal-projecting and neurosecretory neurons in the paraventricular nucleus of the male rat. J. Comp. Neurol. 2006, 499:911-923.
34. Blair M.L., Piekut D., Want A., Olschowka J.A. Role of the hypothalamic paraventricular nucleus in cardiovascular regulation. Clin. Exp. Pharmacol. Physiol. 1996, 23:161-165.
35. Bondy C.A., Whitnall M.H., Brady L.S., Gainer H. Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications. Cell. Mol. Neurobiol. 1989, 9:427-446.
36. Boudaba C., Szabo K., Tasker J.G. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J. Neurosci. 1996, 16:7151-7160.
37. Bradbury M.J., Akana S.F., Dallman M.F. Roles of type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation. Endocrinology 1994, 134:1286-1296.
38. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., Prossnitz E.R., Dun N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol. 2007, 193:311-321.
39. Brinkmann A.O. Molecular mechanisms of androgen action - a historical perspective. Methods Mol. Biol. 2011, 776:3-24.
40. Brinton R.E., McEwen B.S. Regional distinctions in the regulation of type I and type II adrenal steroid receptors in the central nervous system. Neurosci. Res. Commun. 1988, 2:37-45.
41. Brunton P.J., Russell J.A. Allopregnanolone and suppressed hypothalamo-pituitary-adrenal axis stress responses in late pregnancy in the rat. Stress 2011, 14:6-12.
42. Burbach J.P., Lopes da Silva S., Cox J.J., Adan R.A., Cooney A.J., Tsai M.J., Tsai S.Y. Repression of estrogen-dependent stimulation of the oxytocin gene by chicken ovalbumin upstream promoter transcription factor I. J. Biol. Chem. 1994, 269:15046-15053.
43. Burbach J.P., van Schaick H., Lopes da Silva S., Asbreuk C.H., Smidt M.P. Hypothalamic transcription factors and the regulation of the hypothalamo-neurohypophysial system. Adv. Exp. Med. Biol. 1998, 449:29-37.
44. Burbach J.P., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 2001, 81:1197-1267.
45. Burgess L.H., Handa R.J. Chronic estrogen-induced alterations in adrenocorticotropin and corticosterone secretion, and glucocorticoid receptor-mediated functions in female rats. Endocrinology 1992, 131:1261-1269.
46. Burgess L.H., Handa R.J. Estrogen-induced alterations in the regulation of mineralocorticoid and glucocorticoid receptor messenger RNA expression in the female rat anterior pituitary gland and brain. Mol. Cell. Neurosci. 1993, 4:191-198.
47. Burgus R., Dunn T.F., Desiderio D., Ward D.N., Vale W., Guillemin R. Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature 1970, 226:321-325.
48. Cannon W.B. Bodily Changes in Pain, Hunger, Fear and Rage 1915, Applegate and Co., New York.
49. Cannon W.B. Wisdom of the Body 1932, Norton, New York.
50. Cascio C.S., Shinsako J., Dallman M.F. The suprachiasmatic nuclei stimulate evening ACTH secretion in the rat. Brain Res. 1987, 423:173-178.
51. Catalano R.D., Kyriakou T., Chen J., Easton A., Hillhouse E.W. Regulation of corticotropin-releasing hormone type 2 receptors by multiple promoters and alternative splicing: identification of multiple splice variants. Mol. Endocrinol. 2003, 17:395-410.
52. Ceccatelli S., Cintra A., Hokfelt T., Fuxe K., Wikstrom A.C., Gustafsson J.A. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus. Exp. Brain Res. 1989, 78:33-42.
53. Chaban V.V., Lakhter A.J., Micevych P. A membrane estrogen receptor mediates intracellular calcium release in astrocytes. Endocrinology 2004, 145:3788-3795.
54. Chaban V., Li J., McDonald J.S., Rapkin A., Micevych P. Estradiol attenuates the adenosine triphosphate-induced increase of intracellular calcium through group II metabotropic glutamate receptors in rat dorsal root ganglion neurons. J. Neurosci. Res. 2011, 89:1707-1710.
55. Champagne F., Diorio J., Sharma S., Meaney M.J. Naturally occurring variations in maternal behavior in the rat are associated with differences in estrogen-inducible central oxytocin receptors. Proc. Natl. Acad. Sci. USA 2001, 98:12736-12741.
56. Chao H.M., Ma L.Y., McEwen B.S., Sakai R.R. Regulation of glucocorticoid receptor and mineralocorticoid receptor messenger ribonucleic acids by selective agonists in the rat hippocampus. Endocrinology 1998, 139:1810-1814.
57. Chen X.Q., Du J.Z., Wang Y.S. Regulation of hypoxia-induced release of corticotropin-releasing factor in the rat hypothalamus by norepinephrine. Regul. Pept. 2004, 119:221-228.
58. Chen X.N., Zhu H., Meng Q.Y., Zhou J.N. Estrogen receptor-alpha and -beta regulate the human corticotropin-releasing hormone gene through similar pathways. Brain Res. 2008, 1223:1-10.
59. Chu S., Fuller P.J. Identification of a splice variant of the rat estrogen receptor beta gene. Mol. Cell. Endocrinol. 1997, 132:195-199.
60. Cintra A., Bhatnagar M., Chadi G., Tinner B., Lindberg J., Gustafsson J.A., Agnati L.F., Fuxe K. Glial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann. N. Y. Acad. Sci. 1994, 746:42-61. discussion 61-3.
61. Clark J.A., Alves S., Gundlah C., Rocha B., Birzin E.T., Cai S.J., Flick R., Hayes E., Ho K., Warrier S., Pai L., Yudkovitz J., Fleischer R., Colwell L., Li S., Wilkinson H., Schaeffer J., Wilkening R., Mattingly E., Hammond M., Rohrer S.P. Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test. Neuropharmacology 2012, 63:1051-1063.
62. Coirini H., Magarinos A.M., De Nicola A.F., Rainbow T.C., McEwen B.S. Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res. 1985, 361:212-216.
63. Cole R.L., Sawchenko P.E. Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2002, 22:959-969.
64. Conway-Campbell B.L., McKenna M.A., Wiles C.C., Atkinson H.C., de Kloet E.R., Lightman S.L. Proteasome-dependent down-regulation of activated nuclear hippocampal glucocorticoid receptors determines dynamic responses to corticosterone. Endocrinology 2007, 148:5470-5477.
65. Conway-Campbell B.L., Pooley J.R., Hager G.L., Lightman S.L. Molecular dynamics of ultradian glucocorticoid receptor action. Mol. Cell. Endocrinol. 2012, 348:383-393.
66. Cota D., Steiner M.A., Marsicano G., Cervino C., Herman J.P., Grubler Y., Stalla J., Pasquali R., Lutz B., Stalla G.K., Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 2007, 148:1574-1581.
67. Coyne M.D., Kitay J.I. Effect of ovariectomy on pituitary secretion of ACTH. Endocrinology 1969, 85:1097-1102.
68. Coyne M.D., Kitay J.I. Effect of orchiectomy on pituitary secretion of ACTH. Endocrinology 1971, 89:1024-1028.
69. Critchlow V., Liebelt R.A., Bar-Sela M., Mountcastle W., Lipscomb H.S. Sex difference in resting pituitary-adrenal function in the rat. Am. J. Physiol. 1963, 205:807-815.
70. Crochemore C., Lu J., Wu Y., Liposits Z., Sousa N., Holsboer F., Almeida O.F. Direct targeting of hippocampal neurons for apoptosis by glucocorticoids is reversible by mineralocorticoid receptor activation. Mol. Psychiatry 2005, 10:790-798.
71. Cullinan W.E., Herman J.P., Watson S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol. 1993, 332:1-20.
72. Cummings S., Seybold V. Relationship of alpha-1- and alpha-2-adrenergic-binding sites to regions of the paraventricular nucleus of the hypothalamus containing corticotropin-releasing factor and vasopressin neurons. Neuroendocrinology 1988, 47:523-532.
73. Cunningham E.T., Bohn M.C., Sawchenko P.E. Organization of adrenergic inputs to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Comp. Neurol. 1990, 292:651-667.
74. Cunningham R.L., Lumia A.R., McGinnis M.Y. Androgen receptors, sex behavior, and aggression. Neuroendocrinology 2012, 96:131-140.
75. Dabrowska J., Hazra R., Ahern T.H., Guo J.D., McDonald A.J., Mascagni F., Muller J.F., Young L.J., Rainnie D.G. Neuroanatomical evidence for reciprocal regulation of the corticotrophin-releasing factor and oxytocin systems in the hypothalamus and the bed nucleus of the stria terminalis of the rat: implications for balancing stress and affect. Psychoneuroendocrinology 2011, 36:1312-1326.
76. Dallman M.F. Fast glucocorticoid actions on brain: back to the future. Front. Neuroendocrinol. 2005, 26:103-108.
77. Dallman M.F., Engeland W.C., Rose J.C., Wilkinson C.W., Shinsako J., Siedenburg F. Nycthemeral rhythm in adrenal responsiveness to ACTH. Am. J. Physiol. 1978, 235:R210-R218.
78. Dallman M.F., Makara G.B., Roberts J.L., Levin N., Blum M. Corticotrope response to removal of releasing factors and corticosteroids in vivo. Endocrinology 1985, 117:2190-2197.
79. Dallman M.F., Akana S.F., Cascio C.S., Darlington D.N., Jacobson L., Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog. Horm. Res. 1987, 43:113-173.
80. Dallman M.F., Akana S.F., Jacobson L., Levin N., Cascio C.S., Shinsako J. Characterization of corticosterone feedback regulation of ACTH secretion. Ann. N. Y. Acad. Sci. 1987, 512:402-414.
81. Day H.E., Campeau S., Watson S.J., Akil H. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J. Chem. Neuroanat. 1997, 13:115-139.
82. Day H.E., Campeau S., Watson S.J., Akil H. Expression of alpha(1b) adrenoceptor mRNA in corticotropin-releasing hormone-containing cells of the rat hypothalamus and its regulation by corticosterone. J. Neurosci. 1999, 19:10098-10106.
83. De Groot J., Harris G.W. Hypothalmic control of the anterior pituitary gland and blood lymphocytes. J. Physiol. 1950, 111:335-346.
84. de Kloet E.R. Adrenal steroids as modulators of nerve cell function. J. Steroid Biochem. 1984, 20:175-181.
85. de Kloet E.R., Burbach P., Mulder G.H. Localization and role of transcortin-like molecules in the anterior pituitary. Mol. Cell. Endocrinol. 1977, 7:261-273.
86. Denayer S., Helsen C., Thorrez L., Haelens A., Claessens F. The rules of DNA recognition by the androgen receptor. Mol. Endocrinol. 2010, 24:898-913.
87. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci. 1993, 13:3839-3847.
88. DonCarlos L.L., Garcia-Ovejero D., Sarkey S., Garcia-Segura L.M., Azcoitia I. Androgen receptor immunoreactivity in forebrain axons and dendrites in the rat. Endocrinology 2003, 144:3632-3638.
89. DonCarlos L.L., Sarkey S., Lorenz B., Azcoitia I., Garcia-Ovejero D., Huppenbauer C., Garcia-Segura L.M. Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience 2006, 138:801-807.
90. Dong H.W., Swanson L.W. Projections from bed nuclei of the stria terminalis, anteromedial area: cerebral hemisphere integration of neuroendocrine, autonomic, and behavioral aspects of energy balance. J. Comp. Neurol. 2006, 494:142-178.
91. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev. 2001, 38:192-246.
92. Dong H.W., Petrovich G.D., Watts A.G., Swanson L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J. Comp. Neurol. 2001, 436:430-455.
93. Donner N., Handa R.J. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience 2009, 163:705-718.
94. Dunn J.D. Plasma corticosterone responses to electrical stimulation of the bed nucleus of the stria terminalis. Brain Res. 1987, 407:327-331.
95. Dunn A.J., Berridge C.W. Is corticotropin-releasing factor a mediator of stress responses?. Ann. N. Y. Acad. Sci. 1990, 579:183-191.
96. Edinger K.L., Frye C.A. Testosterone's anti-anxiety and analgesic effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Psychoneuroendocrinology 2005, 30:418-430.
97. Ekstrand J., Hellsten J., Tingstrom A. Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex. Neurosci. Lett. 2008, 442:203-207.
98. Ellis G.B., Desjardins C. Male rats secrete luteinizing hormone and testosterone episodically. Endocrinology 1982, 110:1618-1627.
99. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 1994, 14:897-913.
100. Estacio M.A., Yamada S., Tsukamura H., Hirunagi K., Maeda K. Effect of fasting and immobilization stress on estrogen receptor immunoreactivity in the brain in ovariectomized female rats. Brain Res. 1996, 717:55-61.
101. Estrada-Camarena E., Lopez-Rubalcava C., Fernandez-Guasti A. Facilitating antidepressant-like actions of estrogens are mediated by 5-HT1A and estrogen receptors in the rat forced swimming test. Psychoneuroendocrinology 2006, 31:905-914.
102. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
103. Evanson N.K., Tasker J.G., Hill M.N., Hillard C.J., Herman J.P. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 2010, 151:4811-4819.
104. Feldman S., Weidenfeld J. Further evidence for the central effect of dexamethasone at the hypothalamic level in the negative feedback mechanism. Brain Res. 2002, 958:291-296.
105. Ferguson A.V., Latchford K.J., Samson W.K. The paraventricular nucleus of the hypothalamus - a potential target for integrative treatment of autonomic dysfunction. Expert Opin. Ther. Targets 2008, 12:717-727.
106. Figueiredo H.F., Dolgas C.M., Herman J.P. Stress activation of cortex and hippocampus is modulated by sex and stage of estrus. Endocrinology 2002, 143:2534-2540.
107. Figueiredo H.F., Bodie B.L., Tauchi M., Dolgas C.M., Herman J.P. Stress integration after acute and chronic predator stress: differential activation of central stress circuitry and sensitization of the hypothalamo-pituitary-adrenocortical axis. Endocrinology 2003, 144:5249-5258.
108. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
109. Foradori C.D., Weiser M.J., Handa R.J. Non-genomic actions of androgens. Front. Neuroendocrinol. 2008, 29:169-181.
110. Fortier C., Harris G.W., McDonald I.R. The effect of pituitary stalk section on the adrenocortical response to stress in the rabbit. J. Physiol. 1957, 136:344-363.
111. Frahm K.A., Schow M.J., Tobet S.A. The vasculature within the paraventricular nucleus of the hypothalamus in mice varies as a function of development, subnuclear location, and GABA signaling. Horm. Metab. Res. 2012, 44:619-624.
112. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 2003, 83:1017-1066.
113. Frye C.A., Seliga A.M. Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats. Cogn. Affect. Behav. Neurosci. 2001, 1:371-381.
114. Frye C.A., Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm. Behav. 2003, 44:319-326.
115. Frye C.A., Edinger K.L., Lephart E.D., Walf A.A. 3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats. Front. Aging Neurosci. 2010, 2:15.
116. Gaillet S., Lachuer J., Malaval F., Assenmacher I., Szafarczyk A. The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors. Exp. Brain Res. 1991, 87:173-180.
117. Gangloff A., Shi R., Nahoum V., Lin S.X. Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase. FASEB J. 2003, 17:274-276.
118. Garcia-Iglesias B.B., Mendoza-Garrido M.E., Gutierrez-Ospina G., Rangel-Barajas C., Noyola-Diaz M., Terron J.A. Sensitization of restraint-induced corticosterone secretion after chronic restraint in rats: involvement of 5-HT receptors. Neuropharmacology 2013, 71C:216-227.
119. Gasbarri A., Tavares M.C., Rodrigues R.C., Tomaz C., Pom pili A. Estrogen, cognitive functions and emotion: an overview on humans, non-human primates and rodents in reproductive years. Rev. Neurosci. 2012, 23:587-606.
120. Gatson J.W., Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 2007, 148:2458-2464.
121. Gemzik B., Jacob S., Jennings S., Veltman J., Parkinson A. Species differences in 5 alpha-androstane-3 beta,17 beta-diol hydroxylation by rat, monkey, and human prostate microsomes. Arch. Biochem. Biophys. 1992, 296:374-383.
122. Ghosal S., Myers B., Herman J.P. Role of central glucagon-like peptide-1 in stress regulation. Physiol. Behav. 2013, 122:201-207.
123. Gibson A., Hart S.L., Patel S. Effects of 6-hydroxydopamine-induced lesions of the paraventricular nucleus, and of prazosin, on the corticosterone response to restraint in rats. Neuropharmacology 1986, 25:257-260.
124. Gillies G.E., Linton E.A., Lowry P.J. Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 1982, 299:355-357.
125. Goel N., Plyler K.S., Daniels D., Bale T.L. Androgenic influence on serotonergic activation of the HPA stress axis. Endocrinology 2011, 152:2001-2010.
126. Gore-Langton R.E., Armstrong D.T. Follicular steroidogenesis and its control. The Physiology of Reproduction 1994, 571-627. Raven Press Ltd., NY, NY.
127. Gorzalka B.B., Dang S.S. Minireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 2012, 153:1016-1024.
128. Gray T.S., Piechowski R.A., Yracheta J.M., Rittenhouse P.A., Bethea C.L., Van de Kar L.D. Ibotenic acid lesions in the bed nucleus of the stria terminalis attenuate conditioned stress-induced increases in prolactin, ACTH and corticosterone. Neuroendocrinology 1993, 57:517-524.
129. Grove-Strawser D., Boulware M.I., Mermelstein P.G. Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience 2010, 170:1045-1055.
130. Gu Q., Moss R.L. 17 beta-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade. J. Neurosci. 1996, 16:3620-3629.
131. Gu S., Papadopoulou N., Nasir O., Foller M., Alevizopoulos K., Lang F., Stournaras C. Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol. Med. 2011, 17:48-58.
132. Gu G., Roland B., Tomaselli K., Dolman C.S., Lowe C., Heilig J.S. Glucagon-like peptide-1 in the rat brain: distribution of expression and functional implication. J. Comp. Neurol. 2013, 521:2235-2261.
133. Gundlah C., Lu N.Z., Mirkes S.J., Bethea C.L. Estrogen receptor beta (ERbeta) mRNA and protein in serotonin neurons of macaques. Brain Res. Mol. Brain Res. 2001, 91:14-22.
134. Gurdjian E.S. The diencephalon of the albino rat. J. Comp. Neurol. 1927, 43:1-114.
135. Handa R.J., Reid D.L., Resko J.A. Androgen receptors in brain and pituitary of female rats: cyclic changes and comparisons with the male. Biol. Reprod. 1986, 34:293-303.
136. Handa R.J., Roselli C.E., Horton L., Resko J.A. The quantitative distribution of cytosolic androgen receptors in microdissected areas of the male rat brain: effects of estrogen treatment. Endocrinology 1987, 121:233-240.
137. Handa R.J., Burgess L.H., Kerr J.E., O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 1994, 28:464-476.
138. Handa R.J., Nunley K.M., Lorens S.A., Louie J.P., McGivern R.F., Bollnow M.R. Androgen regulation of adrenocorticotropin and corticosterone secretion in the male rat following novelty and foot shock stressors. Physiol. Behav. 1994, 55:117-124.
139. Handa R.J., Sharma D., Uht R. A role for the androgen metabolite, 5alpha androstane 3beta, 17beta diol (3beta-diol) in the regulation of the hypothalamo-pituitary-adrenal axis. Front. Endocrinol. (Lausanne) 2011, 2:65.
140. Handa R.J., Ogawa S., Wang J.M., Herbison A.E. Roles for oestrogen receptor beta in adult brain function. J. Neuroendocrinol. 2012, 24:160-173.
141. Handa R.J., Kudwa A.E., Donner N.C., McGivern R.F., Brown R. Central 5-alpha reduction of testosterone is required for testosterone's inhibition of the hypothalamo-pituitary-adrenal axis response to restraint stress in adult male rats. Brain Res. 2013, 1529:74-82.
142. Harris G.W. Neural control of the pituitary gland. I. The neurohypophysis. Br. Med. J. 1951, 2:559-564.
143. Harris G.W. Neural control of the pituitary gland. II. The adenohypophysis, with special reference to the secretion of A.C.T.H. Br. Med. J. 1951, 2:627-634.
144. Harris G.W., Jacobsohn D. Functional grafts of the anterior pituitary gland. Proc. Roy. Soc. Lond. B Biol. Sci. 1952, 139:263-276.
145. Hawley W.R., Grissom E.M., Martin R.C., Halmos M.B., Bart C.L., Dohanich G.P. Testosterone modulates spatial recognition memory in male rats. Horm. Behav. 2013, 63:559-565.
146. Healy D.P., Printz M.P. Distribution of immunoreactive angiotensin II, angiotensin I, angiotensinogen and renin in the central nervous system of intact and nephrectomized rats. Hypertension 1984, 6:I130-1136.
147. Heisler L.K., Pronchuk N., Nonogaki K., Zhou L., Raber J., Tung L., Yeo G.S., O'Rahilly S., Colmers W.F., Elmquist J.K., Tecott L.H. Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J. Neurosci. 2007, 27:6956-6964.
148. Herman J.P., Wiegand S.J., Watson S.J. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations. Endocrinology 1990, 127:2408-2417.
149. Herman J.P., Cullinan W.E., Watson S.J. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J. Neuroendocrinol. 1994, 6:433-442.
150. Herman J.P., Dolgas C.M., Carlson S.L. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors. Neuroscience 1998, 86:449-459.
151. Herman J.P., Cullinan W.E., Ziegler D.R., Tasker J.G. Role of the paraventricular nucleus microenvironment in stress integration. Eur. J. Neurosci. 2002, 16:381-385.
152. Herman J.P., Mueller N.K., Figueiredo H., Cullinan W.E. Neurocircuit regulation of the hypothalamic-pituitary-adrenocortical stress response - an overview. Handbook of Stress and the Brain 2005, 405-418. Elsevier. T. Steckler, N.H. Kalin, J.M. Reul (Eds.).
153. Herman J.P., Flak J., Jankord R. Chronic stress plasticity in the hypothalamic paraventricular nucleus. Prog. Brain Res. 2008, 170:353-364.
154. Heuser I., Bissette G., Dettling M., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Nemeroff C.B., Holsboer F. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety 1998, 8:71-79.
155. Hill M.N., Tasker J.G. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 2012, 204:5-16.
156. Hill M.N., Patel S., Campolongo P., Tasker J.G., Wotjak C.T., Bains J.S. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 2010, 30:14980-14986.
157. Hiroi R., Lacagnina A.F., Hinds L.R., Carbone D.G., Uht R.M., Handa R.J. The androgen metabolite, 5alpha-androstane-3beta,17beta-diol (3beta-diol), activates the oxytocin promoter through an estrogen receptor-beta pathway. Endocrinology 2013, 154:1802-1812.
158. Hisano S., Fukui Y., Chikamori-Aoyama M., Aizawa T., Shibasaki T. Reciprocal synaptic relations between CRF-immunoreactive- and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus. Brain Res. 1993, 620:343-346.
159. Hornby P.J., Piekut D.T. Opiocortin and catecholamine input to CRF-immunoreactive neurons in rat forebrain. Peptides 1989, 10:1139-1146.
160. Hosoya Y., Sugiura Y., Okado N., Loewy A.D., Kohno K. Descending input from the hypothalamic paraventricular nucleus to sympathetic preganglionic neurons in the rat. Exp. Brain Res. 1991, 85:10-20.
161. Hrabovszky E., Kallo I., Steinhauser A., Merchenthaler I., Coen C.W., Petersen S.L., Liposits Z. Estrogen receptor-beta in oxytocin and vasopressin neurons of the rat and human hypothalamus: immunocytochemical and in situ hybridization studies. J. Comp. Neurol. 2004, 473:315-333.
162. Htun H., Holth L.T., Walker D., Davie J.R., Hager G.L. Direct visualization of the human estrogen receptor alpha reveals a role for ligand in the nuclear distribution of the receptor. Mol. Biol. Cell 1999, 10:471-486.
163. Huang Q., Zhu H., Fischer D.F., Zhou J.N. An estrogenic effect of 5alpha-androstane-3beta, 17beta-diol on the behavioral response to stress and on CRH regulation. Neuropharmacology 2008, 54:1233-1238.
164. Hughes Z.A., Liu F., Platt B.J., Dwyer J.M., Pulicicchio C.M., Zhang G., Schechter L.E., Rosenzweig-Lipson S., Day M. WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology 2008, 54:1136-1142.
165. Ibuka N., Kawamura H. Loss of circadian rhythm in sleep-wakefulness cycle in the rat by suprachiasmatic nucleus lesions. Brain Res. 1975, 96:76-81.
166. Imaki T., Nahan J.L., Rivier C., Sawchenko P.E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 1991, 11:585-599.
167. Imwalle D.B., Gustafsson J.A., Rissman E.F. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol. Behav. 2005, 84:157-163.
168. Isgor C., Cecchi M., Kabbaj M., Akil H., Watson S.J. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone. Neuroscience 2003, 121:837-845.
169. Ishizaki F., Nishiyama T., Kawasaki T., Miyashiro Y., Hara N., Takizawa I., Naito M., Takahashi K. Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer. Sci. Rep. 2013, 3:1528.
170. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., Kunzel H.E., Pfennig A., Uhr M., Holsboer F. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biol. Psychiatry 2007, 62:47-54.
171. Itoi K., Suda T., Tozawa F., Dobashi I., Ohmori N., Sakai Y., Abe K., Demura H. Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 1994, 135:2177-2182.
172. Itoi K., Helmreich D.L., Lopez-Figueroa M.O., Watson S.J. Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine. J. Neurosci. 1999, 19:5464-5472.
173. Iwasaki-Sekino A., Mano-Otagiri A., Ohata H., Yamauchi N., Shibasaki T. Gender differences in corticotropin and corticosterone secretion and corticotropin-releasing factor mRNA expression in the paraventricular nucleus of the hypothalamus and the central nucleus of the amygdala in response to footshock stress or psychological stress in rats. Psychoneuroendocrinology 2009, 34:226-237.
174. Jansen A.S., Wessendorf M.W., Loewy A.D. Transneuronal labeling of CNS neuropeptide and monoamine neurons after pseudorabies virus injections into the stellate ganglion. Brain Res. 1995, 683:1-24.
175. Jasper M.S., Engeland W.C. Splanchnicotomy increases adrenal sensitivity to ACTH in nonstressed rats. Am. J. Physiol. 1997, 273:E363-E368.
176. Jauregui-Huerta F., Ruvalcaba-Delgadillo Y., Gonzalez-Castaneda R., Garcia-Estrada J., Gonzalez-Perez O., Luquin S. Responses of glial cells to stress and glucocorticoids. Curr. Immunol. Rev. 2010, 6:195-204.
177. Jeanneteau F.D., Lambert W.M., Ismaili N., Bath K.G., Lee F.S., Garabedian M.J., Chao M.V. BDNF and glucocorticoids regulate corticotrophin-releasing hormone (CRH) homeostasis in the hypothalamus. Proc. Natl. Acad. Sci. USA 2012, 109:1305-1310.
178. Jennes L., Conn P.M. Gonadotropin-releasing hormone and its receptors in rat brain. Front. Neuroendocrinol. 1994, 15:51-77.
179. Jin Y., Penning T.M. Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract. Res. Clin. Endocrinol. Metab. 2001, 15:79-94.
180. Jin Y., Penning T.M. Multiple steps determine the overall rate of the reduction of 5alpha-dihydrotestosterone catalyzed by human type 3 3alpha-hydroxysteroid dehydrogenase: implications for the elimination of androgens. Biochemistry 2006, 45:13054-13063.
181. Joels M., Karst H. Corticosteroid effects on calcium signaling in limbic neurons. Cell Calcium 2012, 51:277-283.
182. Joels M., Krugers H.J., Lucassen P.J., Karst H. Corticosteroid effects on cellular physiology of limbic cells. Brain Res. 2009, 1293:91-100.
183. Joels M., Sarabdjitsingh R.A., Karst H. Unraveling the time domains of corticosteroid hormone influences on brain activity: rapid, slow, and chronic modes. Pharmacol. Rev. 2012, 64:901-938.
184. Ju G., Liu S., Tao J. Projections from the hypothalamus and its adjacent areas to the posterior pituitary in the rat. Neuroscience 1986, 19:803-828.
185. Kageyama K., Yamagata S., Akimoto K., Sugiyama A., Murasawa S., Suda T. Action of glucagon-like peptide 1 and glucose levels on corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Mol. Cell. Endocrinol. 2012, 362:221-226.
186. Kalil B., Leite C.M., Carvalho-Lima M., Anselmo-Franci J.A. Role of sex steroids in progesterone and corticosterone response to acute restraint stress in rats: sex differences. Stress 2013.
187. Kalsbeek A., van Heerikhuize J.J., Wortel J., Buijs R.M. A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J. Neurosci. 1996, 16:5555-5565.
188. Kalsbeek A., Verhagen L.A., Schalij I., Foppen E., Saboureau M., Bothorel B., Buijs R.M., Pevet P. Opposite actions of hypothalamic vasopressin on circadian corticosterone rhythm in nocturnal versus diurnal species. Eur. J. Neurosci. 2008, 27:818-827.
189. Kalsbeek A., van der Spek R., Lei J., Endert E., Buijs R.M., Fliers E. Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis. Mol. Cell. Endocrinol. 2012, 349:20-29.
190. Kandi P., Hayslett R.L. Nicotine and 17beta-estradiol produce an antidepressant-like effect in female ovariectomized rats. Brain Res. Bull. 2011, 84:224-228.
191. Kaneko M., Hiroshige T., Shinsako J., Dallman M.F. Diurnal changes in amplification of hormone rhythms in the adrenocortical system. Am. J. Physiol. 1980, 239:R309-R316.
192. Kaneko M., Kaneko K., Shinsako J., Dallman M.F. Adrenal sensitivity to adrenocorticotropin varies diurnally. Endocrinology 1981, 109:70-75.
193. Karst H., Joels M. Corticosterone slowly enhances miniature excitatory postsynaptic current amplitude in mice CA1 hippocampal cells. J. Neurophysiol. 2005, 94:3479-3486.
194. Kash T.L., Winder D.G. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006, 51:1013-1022.
195. Keller-Wood M. ACTH responses to hypotension and feedback inhibition of ACTH increased by chronic progesterone treatment. Am. J. Physiol. 1998, 274:R81-R87.
196. Kelly M.J., Ronnekleiv O.K. Membrane-initiated actions of estradiol that regulate reproduction, energy balance and body temperature. Front. Neuroendocrinol. 2012, 33:376-387.
197. Kelly M.J., Ronnekleiv O.K. A selective membrane estrogen receptor agonist maintains autonomic functions in hypoestrogenic states. Brain Res. 2013.
198. Kelly M.J., Moss R.L., Dudley C.A. The effects of microelectrophoretically applied estrogen, cortisol and acetylcholine on medial preoptic-septal unit activity throughout the estrous cycle of the female rat. Exp. Brain Res. 1977, 30:53-64.
199. Kerr J.E., Beck S.G., Handa R.J. Androgens selectively modulate C-fos messenger RNA induction in the rat hippocampus following novelty. Neuroscience 1996, 74:757-766.
200. Kessler R.C. Epidemiology of women and depression. J. Affect. Disord. 2003, 74:5-13.
201. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: lifetime prevalence, chronicity and recurrence. J. Affect. Disord. 1993, 29:85-96.
202. Khan A.M., Ponzio T.A., Sanchez-Watts G., Stanley B.G., Hatton G.I., Watts A.G. Catecholaminergic control of mitogen-activated protein kinase signaling in paraventricular neuroendocrine neurons in vivo and in vitro: a proposed role during glycemic challenges. J. Neurosci. 2007, 27:7344-7360.
203. King J.C., Tobet S.A., Snavely F.L., Arimura A.A. LHRH immunopositive cells and their projections to the median eminence and organum vasculosum of the lamina terminalis. J. Comp. Neurol. 1982, 209:287-300.
204. Kinzig K.P., D'Alessio D.A., Herman J.P., Sakai R.R., Vahl T.P., Figueiredo H.F., Murphy E.K., Seeley R.J. CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J. Neurosci. 2003, 23:6163-6170.
205. Kiss J.Z. Anatomical studies of cholecystokinin in neurons and pathways involved in neuroendocrine regulation. Ann. N. Y. Acad. Sci. 1985, 448:144-151.
206. Kiss A., Aguilera G. Participation of alpha 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinology 1992, 56:153-160.
207. Kiss J.Z., Mezey E., Skirboll L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc. Natl. Acad. Sci. USA 1984, 81:1854-1858.
208. Kiss J.Z., Martos J., Palkovits M. Hypothalamic paraventricular nucleus: a quantitative analysis of cytoarchitectonic subdivisions in the rat. J. Comp. Neurol. 1991, 313:563-573.
209. Kitay J.I. Pituitary-adrenal function in the rat after gonadectomy and gonadal hormone replacement. Endocrinology 1963, 73:253-260.
210. Kitay J.I. Depression of adrenal corticosterone production in oophorectomized rats. Endocrinology 1965, 77:1048-1052.
211. Kitazawa S., Shioda S., Nakai Y. Catecholaminergic innervation of neurons containing corticotropin-releasing factor in the paraventricular nucleus of the rat hypothalamus. Acta Anat. (Basel) 1987, 129:337-343.
212. Koegler-Muly S.M., Owens M.J., Ervin G.N., Kilts C.D., Nemeroff C.B. Potential corticotropin-releasing factor pathways in the rat brain as determined by bilateral electrolytic lesions of the central amygdaloid nucleus and the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 1993, 5:95-98.
213. Kolber B.J., Muglia L.J. Defining brain region-specific glucocorticoid action during stress by conditional gene disruption in mice. Brain Res. 2009, 1293:85-90.
214. Koohi M.K., Ivell R., Walther N. Transcriptional activation of the oxytocin promoter by oestrogens uses a novel non-classical mechanism of oestrogen receptor action. J. Neuroendocrinol. 2005, 17:197-207.
215. Koutcherov Y., Mai J.K., Ashwell K.W., Paxinos G. Organization of the human paraventricular hypothalamic nucleus. J. Comp. Neurol. 2000, 423:299-318.
216. Kovacs K., Kiss J.Z., Makara G.B. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 1986, 44:229-234.
217. Kovacs K.J., Foldes A., Sawchenko P.E. Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons. J. Neurosci. 2000, 20:3843-3852.
218. Kow L.M., Easton A., Pfaff D.W. Acute estrogen potentiates excitatory responses of neurons in rat hypothalamic ventromedial nucleus. Brain Res. 2005, 1043:124-131.
219. Krezel W., Dupont S., Krust A., Chambon P., Chapman P.F. Increased anxiety and synaptic plasticity in estrogen receptor beta-deficient mice. Proc. Natl. Acad. Sci. USA 2001, 98:12278-12282.
220. Kritzer M. The distribution of immunoreactivity for intracellular androgen receptors in the cerebral cortex of hormonally intact adult male and female rats: localization in pyramidal neurons making corticocortical connections. Cereb. Cortex 2004, 14:268-280.
221. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
222. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 1996, 93:5925-5930.
223. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
224. Laflamme N., Nappi R.E., Drolet G., Labrie C., Rivest S. Expression and neuropeptidergic characterization of estrogen receptors (ERalpha and ERbeta) throughout the rat brain: anatomical evidence of distinct roles of each subtype. J. Neurobiol. 1998, 36:357-378.
225. Lalmansingh A.S., Uht R.M. Estradiol regulates corticotropin-releasing hormone gene (crh) expression in a rapid and phasic manner that parallels estrogen receptor-alpha and -beta recruitment to a 3',5'-cyclic adenosine 5'-monophosphate regulatory region of the proximal crh promoter. Endocrinology 2008, 149:346-357.
226. Lambert J.J., Belelli D., Harney S.C., Peters J.A., Frenguelli B.G. Modulation of native and recombinant GABA(A) receptors by endogenous and synthetic neuroactive steroids. Brain Res. Brain Res. Rev. 2001, 37:68-80.
227. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176.
228. Larkin J.W., Binks S.L., Li Y., Selvage D. The role of oestradiol in sexually dimorphic hypothalamic-pituitary-adrena axis responses to intracerebroventricular ethanol administration in the rat. J. Neuroendocrinol. 2010, 22:24-32.
229. Larsen P.J., Tang-Christensen M., Jessop D.S. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 1997, 138:4445-4455.
230. Lawrence A.J., Jarrott B. Neurochemical modulation of cardiovascular control in the nucleus tractus solitarius. Prog. Neurobiol. 1996, 48:21-53.
231. Lawson A., Ahima R., Krozowski Z., Harlan R. Postnatal development of corticosteroid receptor immunoreactivity in the rat hippocampus. Brain Res. Dev. Brain Res. 1991, 62:69-79.
232. Lee K.S., Han T.H., Jo J.Y., Kang G., Lee S.Y., Ryu P.D., Im J.H., Jeon B.H., Park J.B. Serotonin inhibits GABA synaptic transmission in presympathetic paraventricular nucleus neurons. Neurosci. Lett. 2008, 439:138-142.
233. Lephart E.D. Brain 5alpha-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function. Mol. Cell. Neurosci. 1993, 4:473-484.
234. Leret M.L., Molina-Holgado F., Gonzalez M.I. The effect of perinatal exposure to estrogens on the sexually dimorphic response to novelty. Physiol. Behav. 1994, 55:371-373.
235. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 2005, 19:1951-1959.
236. Levine J.E., Duffy M.T. Simultaneous measurement of luteinizing hormone (LH)-releasing hormone, LH, and follicle-stimulating hormone release in intact and short-term castrate rats. Endocrinology 1988, 122:2211-2221.
237. Levine J.E., Pau K.Y., Ramirez V.D., Jackson G.L. Simultaneous measurement of luteinizing hormone-releasing hormone and luteinizing hormone release in unanesthetized, ovariectomized sheep. Endocrinology 1982, 111:1449-1455.
238. Levine J.E., Bauer-Dantoin A.C., Besecke L.M., Conaghan L.A., Legan S.J., Meredith J.M., Strobl F.J., Urban J.H., Vogelsong K.M., Wolfe A.M. Neuroendocrine regulation of the luteinizing hormone-releasing hormone pulse generator in the rat. Recent Prog. Horm. Res. 1991, 47:97-151. discussion 151-3.
239. Levkovitz Y., Segal M. Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation. J. Neurosci. 1997, 17:5591-5598.
240. Levy B.H., Tasker J.G. Synaptic regulation of the hypothalamic-pituitary-adrenal axis and its modulation by glucocorticoids and stress. Front. Cell Neurosci. 2012, 6:24.
241. Li X.F., Kinsey-Jones J.S., Cheng Y., Knox A.M., Lin Y., Petrou N.A., Roseweir A., Lightman S.L., Milligan S.R., Millar R.P., O'Byrne K.T. Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS ONE 2009, 4:e8334.
242. Lightman S.L., Windle R.J., Julian M.D., Harbuz M.S., Shanks N., Wood S.A., Kershaw Y.M., Ingram C.D. Significance of pulsatility in the HPA axis. Novartis Found. Symp. 2000, 227:244-257. discussion 257-60.
243. Lincoln G.A., Fraser H.M., Abbott M.P. Blockade of pulsatile LH, FSH and testosterone secretion in rams by constant infusion of an LHRH agonist. J. Reprod. Fertil. 1986, 77:587-597.
244. Lind R.W., Swanson L.W., Sawchenko P.E. Anatomical evidence that neural circuits related to the subfornical organ contain angiotensin II. Brain Res. Bull. 1985, 15:79-82.
245. Liposits Z., Paull W.K., Setalo G., Vigh S. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis. Histochemistry 1985, 83:5-16.
246. Liposits Z., Sherman D., Phelix C., Paull W.K. A combined light and electron microscopic immunocytochemical method for the simultaneous localization of multiple tissue antigens. Tyrosine hydroxylase immunoreactive innervation of corticotropin releasing factor synthesizing neurons in the paraventricular nucleus of the rat. Histochemistry 1986, 85:95-106.
247. Liposits Z., Uht R.M., Harrison R.W., Gibbs F.P., Paull W.K., Bohn M.C. Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochemistry 1987, 87:407-412.
248. Liu J., Bisschop P.H., Eggels L., Foppen E., Fliers E., Zhou J.N., Kalsbeek A. Intrahypothalamic estradiol modulates hypothalamus-pituitary-adrenal-axis activity in female rats. Endocrinology 2012, 153:3337-3344.
249. Lu N.Z., Shlaes T.A., Gundlah C., Dziennis S.E., Lyle R.E., Bethea C.L. Ovarian steroid action on tryptophan hydroxylase protein and serotonin compared to localization of ovarian steroid receptors in midbrain of guinea pigs. Endocrine 1999, 11:257-267.
250. Luine V.N., Frankfurt M. Estrogens facilitate memory processing through membrane mediated mechanisms and alterations in spine density. Front. Neuroendocrinol. 2012, 33:388-402.
251. Luiten P.G., ter Horst G.J., Karst H., Steffens A.B. The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord. Brain Res. 1985, 329:374-378.
252. Lund T.D., Munson D.J., Haldy M.E., Handa R.J. Dihydrotestosterone may inhibit hypothalamo-pituitary-adrenal activity by acting through estrogen receptor in the male mouse. Neurosci. Lett. 2004, 365:43-47.
253. Lund T.D., Munson D.J., Haldy M.E., Handa R.J. Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus. J. Neuroendocrinol. 2004, 16:272-278.
254. Lund T.D., Rovis T., Chung W.C., Handa R.J. Novel actions of estrogen receptor-beta on anxiety-related behaviors. Endocrinology 2005, 146:797-807.
255. Lund T.D., Hinds L.R., Handa R.J. The androgen 5alpha-dihydrotestosterone and its metabolite 5alpha-androstan-3beta, 17beta-diol inhibit the hypothalamo-pituitary-adrenal response to stress by acting through estrogen receptor beta-expressing neurons in the hypothalamus. J. Neurosci. 2006, 26:1448-1456.
256. Luoma J.I., Boulware M.I., Mermelstein P.G. Caveolin proteins and estrogen signaling in the brain. Mol. Cell. Endocrinol. 2008, 290:8-13.
257. Maeda K., Ohkura S., Uenoyama Y., Wakabayashi Y., Oka Y., Tsukamura H., Okamura H. Neurobiological mechanisms underlying GnRH pulse generation by the hypothalamus. Brain Res. 2010, 1364:103-115.
258. Malkoski S.P., Dorin R.I. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene. Mol. Endocrinol. 1999, 13:1629-1644.
259. Malkoski S.P., Handanos C.M., Dorin R.I. Localization of a negative glucocorticoid response element of the human corticotropin releasing hormone gene. Mol. Cell. Endocrinol. 1997, 127:189-199.
260. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
261. Mantella R.C., Vollmer R.R., Rinaman L., Li X., Amico J.A. Enhanced corticosterone concentrations and attenuated Fos expression in the medial amygdala of female oxytocin knockout mice exposed to psychogenic stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R1494-R1504.
262. McAllister C.E., Creech R.D., Kimball P.A., Muma N.A., Li Q. GPR30 is necessary for estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the rat hypothalamus. Psychoneuroendocrinology 2012, 37:1248-1260.
263. McCann S.M. Effect of hypothalamic lesions on the adrenal cortical response to stress in the rat. Am. J. Physiol. 1953, 175:13-20.
264. McCann S.M., Brobeck J.R. Evidence for a role of the supraopticohypophyseal system in regulation of adrenocorticotrophin secretion. Proc. Soc. Exp. Biol. Med. 1954, 87:318-324.
265. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 1998, 338:171-179.
266. McGimsey W.C., Cidlowski J.A., Stumpf W.E., Sar M. Immunocytochemical localization of the glucocorticoid receptor in rat brain, pituitary, liver, and thymus with two new polyclonal antipeptide antibodies. Endocrinology 1991, 129:3064-3072.
267. McGinnis M.Y., Davis P.G., Meaney M.J., Singer M., McEwen B.S. In vitro measurement of cytosol and cell nuclear androgen receptors in male rat brain and pituitary. Brain Res. 1983, 275:75-82.
268. McIntyre D.C., Kent P., Hayley S., Merali Z., Anisman H. Influence of psychogenic and neurogenic stressors on neuroendocrine and central monoamine activity in fast and slow kindling rats. Brain Res. 1999, 840:65-74.
269. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 1999, 69:3-12.
270. Meijer O.C., de Lange E.C., Breimer D.D., de Boer A.G., Workel J.O., de Kloet E.R. Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice. Endocrinology 1998, 139:1789-1793.
271. Meitzen J., Mermelstein P.G. Estrogen receptors stimulate brain region specific metabotropic glutamate receptors to rapidly initiate signal transduction pathways. J. Chem. Neuroanat. 2011, 42:236-241.
272. Menendez A., Alvarez-Uria M. The development of vascularization in the postnatal rat paraventricular nucleus: a morphometric analysis. J. Hirnforsch. 1987, 28:325-329.
273. Merchenthaler I., Kovacs G., Lavasz G., Setalo G. The preoptico-infundibular LH-RH tract of the rat. Brain Res. 1980, 198:63-74.
274. Merchenthaler I., Lane M., Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 1999, 403:261-280.
275. Mermelstein P.G. Membrane-localised oestrogen receptor alpha and beta influence neuronal activity through activation of metabotropic glutamate receptors. J. Neuroendocrinol. 2009, 21:257-262.
276. Mezey E., Kiss J.Z., Skirboll L.R., Goldstein M., Axelrod J. Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Nature 1984, 310:140-141.
277. Mhyre A.J., Dorsa D.M. Estrogen activates rapid signaling in the brain: role of estrogen receptor alpha and estrogen receptor beta in neurons and glia. Neuroscience 2006, 138:851-858.
278. Micevych P.E., Mermelstein P.G. Membrane estrogen receptors acting through metabotropic glutamate receptors: an emerging mechanism of estrogen action in brain. Mol. Neurobiol. 2008, 38:66-77.
279. Miller W.J., Suzuki S., Miller L.K., Handa R., Uht R.M. Estrogen receptor (ER)beta isoforms rather than ERalpha regulate corticotropin-releasing hormone promoter activity through an alternate pathway. J. Neurosci. 2004, 24:10628-10635.
280. Milner T.A., Reis D.J., Pickel V.M., Aicher S.A., Giuliano R. Ultrastructural localization and afferent sources of corticotropin-releasing factor in the rat rostral ventrolateral medulla: implications for central cardiovascular regulation. J. Comp. Neurol. 1993, 333:151-167.
281. Morimoto M., Morita N., Ozawa H., Yokoyama K., Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study. Neurosci. Res. 1996, 26:235-269.
282. Muglia L.J., Jacobson L., Weninger S.C., Luedke C.E., Bae D.S., Jeong K.H., Majzoub J.A. Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice. J. Clin. Invest. 1997, 99:2923-2929.
283. Murphy D.D., Cole N.B., Greenberger V., Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 1998, 18:2550-2559.
284. Nair R.M., Barrett J.F., Bowers C.Y., Schally A.V. Structure of porcine thyrotropin releasing hormone. Biochemistry 1970, 9:1103-1106.
285. Neigh G.N., Owens M.J., Taylor W.R., Nemeroff C.B. Changes in the vascular area fraction of the hippocampus and amygdala are induced by prenatal dexamethasone and/or adult stress. J. Cereb. Blood Flow Metab. 2010, 30:1100-1104.
286. Neumann I.D. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem. Soc. Trans. 2007, 35:1252-1257.
287. Neumann I.D., Kromer S.A., Toschi N., Ebner K. Brain oxytocin inhibits the (re)activity of the hypothalamo-pituitary-adrenal axis in male rats: involvement of hypothalamic and limbic brain regions. Regul. Pept. 2000, 96:31-38.
288. Neumann I.D., Wigger A., Torner L., Holsboer F., Landgraf R. Brain oxytocin inhibits basal and stress-induced activity of the hypothalamo-pituitary-adrenal axis in male and female rats: partial action within the paraventricular nucleus. J. Neuroendocrinol. 2000, 12:235-243.
289. Nomura M., Saito J., Ueta Y., Muglia L.J., Pfaff D.W., Ogawa S. Enhanced up-regulation of corticotropin-releasing hormone gene expression in response to restraint stress in the hypothalamic paraventricular nucleus of oxytocin gene-deficient male mice. J. Neuroendocrinol. 2003, 15:1054-1061.
290. Nomura M., Akama K.T., Alves S.E., Korach K.S., Gustafsson J.A., Pfaff D.W., Ogawa S. Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 2005, 130:445-456.
291. Ochedalski T., Subburaju S., Wynn P.C., Aguilera G. Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 2007, 19:189-197.
292. Ofner P., Sousa R.L., Vena R.L., Krinsky-Feibush P., LeQuesne P.W. Metabolism of radiotestosterone to 3 beta,6 alpha- and 3 beta,7 alpha-dihydroxy 5 alpha-steroids by rat ventral, canine and human prostate in organ culture. J. Steroid Biochem. 1983, 18:415-423.
293. Ogura E., Kageyama K., Hanada K., Kasckow J., Suda T. Effects of estradiol on regulation of corticotropin-releasing factor gene and interleukin-6 production via estrogen receptor type beta in hypothalamic 4B cells. Peptides 2008, 29:456-464.
294. Olijslagers J.E., de Kloet E.R., Elgersma Y., van Woerden G.M., Joels M., Karst H. Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur. J. Neurosci. 2008, 27:2542-2550.
295. Oster H., Damerow S., Kiessling S., Jakubcakova V., Abraham D., Tian J., Hoffmann M.W., Eichele G. The circadian rhythm of glucocorticoids is regulated by a gating mechanism residing in the adrenal cortical clock. Cell Metab. 2006, 4:163-173.
296. Overstreet, D.H., Osterlund, M., Dahllund, J., Appelqvist, T., Lindstrom, E., Ryan, C.N., Witt, M.R., 2006. Estrogen receptor beta agonists reduce exaggerated swim test immobility in a genetic animal model of depression. In: Abstract 476.11. Society for Neuroscience 36th Annual Meeting, Atlanta, GA.
297. Oyola M.G., Portillo W., Reyna A., Foradori C.D., Kudwa A., Hinds L., Handa R.J., Mani S.K. Anxiolytic effects and neuroanatomical targets of estrogen receptor-beta (ERbeta) activation by a selective ERbeta agonist in female mice. Endocrinology 2012, 153:837-846.
298. Pacak K. Stressor-specific activation of the hypothalamic-pituitary-adrenocortical axis. Physiol. Res. 2000, 49(Suppl. 1):S11-S17.
299. Pacak K., Palkovits M., Kvetnansky R., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the paraventricular nucleus of rats with brainstem hemisections: a microdialysis study. Neuroendocrinology 1993, 58:196-201.
300. Pacak K., Palkovits M., Kopin I.J., Goldstein D.S. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front. Neuroendocrinol. 1995, 16:89-150.
301. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277:1508-1510.
302. Pak T.R., Chung W.C., Roberts J.L., Handa R.J. Ligand-independent effects of estrogen receptor beta on mouse gonadotropin-releasing hormone promoter activity. Endocrinology 2006, 147:1924-1931.
303. Pak T., Chung W., Handa R. Estrogen receptor-beta mediates DHT-induced stimulation of the arginine vasopressin promoter in neuronal cells. Endocrinology 2007.
304. Palermo-Neto J., Dorce V.A. Influences of estrogen and/or progesterone on some dopamine related behavior in rats. Gen. Pharmacol. 1990, 21:83-87.
305. Papadimitriou A., Priftis K.N. Regulation of the hypothalamic-pituitary-adrenal axis. NeuroImmunoModulation 2009, 16:265-271.
306. Papadopoulou N., Papakonstanti E.A., Kallergi G., Alevizopoulos K., Stournaras C. Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact. IUBMB Life 2009, 61:56-61.
307. Patchev V.K., Hassan A.H., Holsboer D.F., Almeida O.F. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology 1996, 15:533-540.
308. Patisaul H.B., Scordalakes E.M., Young L.J., Rissman E.F. Oxytocin, but not oxytocin receptor, is regulated by oestrogen receptor beta in the female mouse hypothalamus. J. Neuroendocrinol. 2003, 15:787-793.
309. Pecoraro N., Dallman M.F., Warne J.P., Ginsberg A.B., Laugero K.D., la Fleur S.E., Houshyar H., Gomez F., Bhargava A., Akana S.F. From Malthus to motive: how the HPA axis engineers the phenotype, yoking needs to wants. Prog. Neurobiol. 2006, 79:247-340.
310. Philibert, D., Moguilewsky, M., 1983. RU 28362, a useful tool for the characterization of glucocorticoid and mineralocorticoid receptors. In: 65th Annual Meeting of the Endocrine Soc. P335.
311. Platania P., Laureanti F., Bellomo M., Giuffrida R., Giuffrida-Stella A.M., Catania M.V., Sortino M.A. Differential expression of estrogen receptors alpha and beta in the spinal cord during postnatal development: localization in glial cells. Neuroendocrinology 2003, 77:334-340.
312. Plotsky P.M., Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Endocrinology 1987, 120:1361-1369.
313. Plotsky P.M., Cunningham E.T., Widmaier E.P. Catecholaminergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocr. Rev. 1989, 10:437-458.
314. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
315. Porter R.W. Hypothalamic involvement in the pituitary-adrenocortical response to stress stimuli. Am. J. Physiol. 1953, 172:515-519.
316. Prewitt C.M., Herman J.P. Anatomical interactions between the central amygdaloid nucleus and the hypothalamic paraventricular nucleus of the rat: a dual tract-tracing analysis. J. Chem. Neuroanat. 1998, 15:173-185.
317. Price R.H., Butler C.A., Webb P., Uht R., Kushner P., Handa R.J. A splice variant of estrogen receptor beta missing exon 3 displays altered subnuclear localization and capacity for transcriptional activation. Endocrinology 2001, 142:2039-2049.
318. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
319. Pyner S., Coote J.H. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 2000, 100:549-556.
320. Quirk S.J., Funder J.W. Steroid receptors, and the generation of closely coupled/biphasic dose-response curves. J. Steroid Biochem. 1988, 30:9-15.
321. Raadsheer F.C., Sluiter A.A., Ravid R., Tilders F.J., Swaab D.F. Localization of corticotropin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res. 1993, 615:50-62.
322. Rabadan-Diehl C., Makara G., Kiss A., Zelena D., Aguilera G. Regulation of pituitary corticotropin releasing hormone (CRH) receptor mRNA and CRH binding during adrenalectomy: role of glucocorticoids and hypothalamic factors. J. Neuroendocrinol. 1997, 9:689-697.
323. Rajkowska G., Miguel-Hidalgo J.J. Gliogenesis and glial pathology in depression. CNS Neurol. Disord.: Drug Targets 2007, 6:219-233.
324. Reul J.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 1985, 117:2505-2511.
325. Reul J.M., Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2002, 2:23-33.
326. Reul J.M., de Kloet E.R., van Sluijs F.J., Rijnberk A., Rothuizen J. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary. Endocrinology 1990, 127:907-915.
327. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
328. Rho J.H., Swanson L.W. A morphometric analysis of functionally defined subpopulations of neurons in the paraventricular nucleus of the rat with observations on the effects of colchicine. J. Neurosci. 1989, 9:1375-1388.
329. Rhodes C.H., Morrell J.I., Pfaff D.W. Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin, and vasopressin. J. Comp. Neurol. 1981, 198:45-64.
330. Rhodes M.E., Kennell J.S., Belz E.E., Czambel R.K., Rubin R.T. Rat estrous cycle influences the sexual diergism of HPA axis stimulation by nicotine. Brain Res. Bull. 2004, 64:205-213.
331. Richard S., Zingg H.H. The human oxytocin gene promoter is regulated by estrogens. J. Biol. Chem. 1990, 265:6098-6103.
332. Richard S., Zingg H.H. Identification of a retinoic acid response element in the human oxytocin promoter. J. Biol. Chem. 1991, 266:21428-21433.
333. Ring R.H. The central vasopressinergic system: examining the opportunities for psychiatric drug development. Curr. Pharm. Des. 2005, 11:205-225.
334. Rivier C., Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 1983, 113:939-942.
335. Rizk A., Robertson J., Raber J. Behavioral performance of tfm mice supports the beneficial role of androgen receptors in spatial learning and memory. Brain Res. 2005, 1034:132-138.
336. Rizner T.L., Lin H.K., Peehl D.M., Steckelbroeck S., Bauman D.R., Penning T.M. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. Endocrinology 2003, 144:2922-2932.
337. Rocha B.A., Fleischer R., Schaeffer J.M., Rohrer S.P., Hickey G.J. 17 Beta-estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-beta knockout (BERKO) mice. Psychopharmacology 2005, 179:637-643.
338. Roland B.L., Sawchenko P.E. Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Comp. Neurol. 1993, 332:123-143.
339. Roselli C.E. Sex differences in androgen receptors and aromatase activity in microdissected regions of the rat brain. Endocrinology 1991, 128:1310-1316.
340. Roselli C.E., Horton L.E., Resko J.A. Distribution and regulation of aromatase activity in the rat hypothalamus and limbic system. Endocrinology 1985, 117:2471-2477.
341. Roselli C.E., Abdelgadir S.E., Resko J.A. Regulation of aromatase gene expression in the adult rat brain. Brain Res. Bull. 1997, 44:351-357.
342. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 1990, 11:80-91.
343. Rossi D.V., Dai Y., Thomas P., Carrasco G.A., DonCarlos L.L., Muma N.A., Li Q. Estradiol-induced desensitization of 5-HT1A receptor signaling in the paraventricular nucleus of the hypothalamus is independent of estrogen receptor-beta. Psychoneuroendocrinology 2010, 35:1023-1033.
344. Roy B.N., Reid R.L., Van Vugt D.A. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinology 1999, 140:2191-2198.
345. Rozeboom A.M., Akil H., Seasholtz A.F. Mineralocorticoid receptor overexpression in forebrain decreases anxiety-like behavior and alters the stress response in mice. Proc. Natl. Acad. Sci. USA 2007, 104:4688-4693.
346. Rubinow D.R., Roca C.A., Schmidt P.J., Danaceau M.A., Putnam K., Cizza G., Chrousos G., Nieman L. Testosterone suppression of CRH-stimulated cortisol in men. Neuropsychopharmacology 2005, 30:1906-1912.
347. Safe S., Kim K. Nonclassical genomic ER/Sp and ER/AP-1 signaling pathways. J. Mol. Endocrinol. 2008.
348. Saijo K., Collier J.G., Li A.C., Katzenellenbogen J.A., Glass C.K. An ADIOL-ERbeta-CtBP transrepression pathway negatively regulates microglia-mediated inflammation. Cell 2011, 145:584-595.
349. Sands S.A., Morilak D.A. Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus. Neuroscience 1999, 91:639-649.
350. Santagati S., Melcangi R.C., Celotti F., Martini L., Maggi A. Estrogen receptor is expressed in different types of glial cells in culture. J. Neurochem. 1994, 63:2058-2064.
351. Saper C.B. Central autonomic control. The Rat Nervous System 1995, 107-135. Academic Press, San Diego. G. Paxinos (Ed.).
352. Saper C.B., Swanson L.W., Cowan W.M. The efferent connections of the ventromedial nucleus of the hypothalamus of the rat. J. Comp. Neurol. 1976, 169:409-442.
353. Sapolsky R.M., Krey L.C., McEwen B.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc. Natl. Acad. Sci. USA 1984, 81:6174-6177.
354. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
355. Sar M., Stumpf W.E. Autoradiographic localization of radioactivity in the rat brain after the injection of 1,2-3H-testosterone. Endocrinology 1973, 92:251-256.
356. Sar M., Stumpf W.E. Distribution of androgen target cells in rat forebrain and pituitary after [3H]-dihydrotestosterone administration. J. Steroid Biochem. 1977, 8:1131-1135.
357. Sarabdjitsingh R.A., Conway-Campbell B.L., Leggett J.D., Waite E.J., Meijer O.C., de Kloet E.R., Lightman S.L. Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology 2010, 151:5369-5379.
358. Sarkar S., Fekete C., Legradi G., Lechan R.M. Glucagon like peptide-1 (7-36) amide (GLP-1) nerve terminals densely innervate corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res. 2003, 985:163-168.
359. Sarkey S., Azcoitia I., Garcia-Segura L.M., Garcia-Ovejero D., DonCarlos L.L. Classical androgen receptors in non-classical sites in the brain. Horm. Behav. 2008, 53:753-764.
360. Sato S.M., Johansen J.A., Jordan C.L., Wood R.I. Membrane androgen receptors may mediate androgen reinforcement. Psychoneuroendocrinology 2010, 35:1063-1073.
361. Sawchenko P.E. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res. 1987, 403:213-223.
362. Sawchenko P.E. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res. 1987, 437:253-263.
363. Sawchenko P.E., Swanson L.W. Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses. Science 1981, 214:685-687.
364. Sawchenko P.E., Swanson L.W. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J. Comp. Neurol. 1982, 205:260-272.
365. Sawchenko P.E., Swanson L.W. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat. J. Comp. Neurol. 1983, 218:121-144.
366. Sawchenko P.E., Swanson L.W., Steinbusch H.W., Verhofstad A.A. The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat. Brain Res. 1983, 277:355-360.
367. Sawchenko P.E., Swanson L.W., Vale W.W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc. Natl. Acad. Sci. USA 1984, 81:1883-1887.
368. Sayers G. The adrenal cortex and homoestasis. Physiol. Rev. 1950, 30:241-320.
369. Schally A.V., Arimura A., Kastin A.J., Matsuo H., Baba Y., Redding T.W., Nair R.M., Debeljuk L., White W.F. Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science 1971, 173:1036-1038.
370. Schally A.V., Baba Y., Nair R.M., Bennett C.D. The amino acid sequence of a peptide with growth hormone-releasing activity isolated from porcine hypothalamus. J. Biol. Chem. 1971, 246:6647-6650.
371. Schally A.V., Nair R.M., Redding T.W., Arimura A. Isolation of the luteinizing hormone and follicle-stimulating hormone-releasing hormone from porcine hypothalami. J. Biol. Chem. 1971, 246:7230-7236.
372. Schlosser S.F., Almeida O.F., Patchev V.K., Yassouridis A., Elands J. Oxytocin-stimulated release of adrenocorticotropin from the rat pituitary is mediated by arginine vasopressin receptors of the V1b type. Endocrinology 1994, 135:2058-2063.
373. Schmidt B.M., Gerdes D., Feuring M., Falkenstein E., Christ M., Wehling M. Rapid, nongenomic steroid actions: a new age?. Front. Neuroendocrinol. 2000, 21:57-94.
374. Schmidt E.M., Gu S., Anagnostopoulou V., Alevizopoulos K., Foller M., Lang F., Stournaras C. Serum- and glucocorticoid-dependent kinase-1-induced cell migration is dependent on vinculin and regulated by the membrane androgen receptor. FEBS J. 2012, 279:1231-1242.
375. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., Lightman S.L. Gonadal steroid replacement reverses gonadectomy-induced changes in the corticosterone pulse profile and stress-induced hypothalamic-pituitary-adrenal axis activity of male and female rats. J. Neuroendocrinol. 2004, 16:989-998.
376. Seale J.V., Wood S.A., Atkinson H.C., Harbuz M.S., Lightman S.L. Postnatal masculinization alters the HPA axis phenotype in the adult female rat. J. Physiol. 2005, 563:265-274.
377. Seale J.V., Wood S.A., Atkinson H.C., Lightman S.L., Harbuz M.S. Organizational role for testosterone and estrogen on adult hypothalamic-pituitary-adrenal axis activity in the male rat. Endocrinology 2005, 146:1973-1982.
378. Seasholtz A.F., Thompson R.C., Douglass J.O. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Mol. Endocrinol. 1988, 2:1311-1319.
379. Seeley R.J., Blake K., Rushing P.A., Benoit S., Eng J., Woods S.C., D'Alessio D. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride. J. Neurosci. 2000, 20:1616-1621.
380. Serova L.I., Harris H.A., Maharjan S., Sabban E.L. Modulation of responses to stress by estradiol benzoate and selective estrogen receptor agonists. J. Endocrinol. 2010, 205:253-262.
381. Shafton A.D., Ryan A., Badoer E. Neurons in the hypothalamic paraventricular nucleus send collaterals to the spinal cord and to the rostral ventrolateral medulla in the rat. Brain Res. 1998, 801:239-243.
382. Shakil T., Hoque A.N., Husain M., Belsham D.D. Differential regulation of gonadotropin-releasing hormone secretion and gene expression by androgen: membrane versus nuclear receptor activation. Mol. Endocrinol. 2002, 16:2592-2602.
383. Shansky R.M., Lipps J. Stress-induced cognitive dysfunction: hormone-neurotransmitter interactions in the prefrontal cortex. Front. Hum. Neurosci. 2013, 7:123.
384. Shapiro R.E., Miselis R.R. The central neural connections of the area postrema of the rat. J. Comp. Neurol. 1985, 234:344-364.
385. Shapiro R.A., Xu C., Dorsa D.M. Differential transcriptional regulation of rat vasopressin gene expression by estrogen receptor alpha and beta. Endocrinology 2000, 141:4056-4064.
386. Sharma D., Handa R.J., Uht R.M. The ERbeta ligand 5alpha-androstane, 3beta,17beta-diol (3beta-diol) regulates hypothalamic oxytocin (Oxt) gene expression. Endocrinology 2012, 153:2353-2361.
387. Shaw G., Fenelon J., Sichlau M., Auchus R.J., Wilson J.D., Renfree M.B. Role of the alternate pathway of dihydrotestosterone formation in virilization of the Wolffian ducts of the tammar wallaby, Macropus eugenii. Endocrinology 2006, 147:2368-2373.
388. Sheng Z., Kawano J., Yanai A., Fujinaga R., Tanaka M., Watanabe Y., Shinoda K. Expression of estrogen receptors (alpha, beta) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences. Neurosci. Res. 2004, 49:185-196.
389. Shepard J.D., Barron K.W., Myers D.A. Stereotaxic localization of corticosterone to the amygdala enhances hypothalamo-pituitary-adrenal responses to behavioral stress. Brain Res. 2003, 963:203-213.
390. Shughrue P.J., Komm B., Merchenthaler I. The distribution of estrogen receptor-beta mRNA in the rat hypothalamus. Steroids 1996, 61:678-681.
391. Shughrue P.J., Lane M.V., Merchenthaler I. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 1996, 137:5159-5162.
392. Shughrue P.J., Scrimo P.J., Merchenthaler I. Evidence for the colocalization of estrogen receptor-beta mRNA and estrogen receptor-alpha immunoreactivity in neurons of the rat forebrain. Endocrinology 1998, 139:5267-5270.
393. Silverman A.J., Hou-Yu A., Chen W.P. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus. Neuroendocrinology 1989, 49:291-299.
394. Simerly R.B. Distribution and regulation of steroid hormone receptor gene expression in the central nervous system. Adv. Neurol. 1993, 59:207-226.
395. Simerly R.B., Young B.J. Regulation of estrogen receptor messenger ribonucleic acid in rat hypothalamus by sex steroid hormones. Mol. Endocrinol. 1991, 5:424-432.
396. Simerly R.B., Chang C., Muramatsu M., Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 1990, 294:76-95.
397. Simonian S.X., Herbison A.E. Differential expression of estrogen receptor alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular nucleus. J. Neuroendocrinol. 1997, 9:803-806.
398. Sladek C.D., Somponpun S.J. Oestrogen receptor beta: role in neurohypophyseal neurones. J. Neuroendocrinol. 2004, 16:365-371.
399. Slob A.K., Bogers H., van Stolk M.A. Effects of gonadectomy and exogenous gonadal steroids on sex differences in open field behaviour of adult rats. Behav. Brain Res. 1981, 2:347-362.
400. Sofroniew M.V., Schrell U. Evidence for a direct projection from oxitocin and vasopressin neurons in the hypothalamic paraventricular nucleus to the medulla oblongata: immunohistochemical visualization of both the horseradish peroxidase transported and the peptide produced by the same neurons. Neurosci. Lett. 1982, 22:211-217.
401. Somponpun S., Sladek C.D. Role of estrogen receptor-beta in regulation of vasopressin and oxytocin release in vitro. Endocrinology 2002, 143:2899-2904.
402. Southworth M.B., Matsumoto A.M., Gross K.M., Soules M.R., Bremner W.J. The importance of signal pattern in the transmission of endocrine information: pituitary gonadotropin responses to continuous and pulsatile gonadotropin-releasing hormone. J. Clin. Endocrinol. Metab. 1991, 72:1286-1289.
403. Spiteri T., Ogawa S., Musatov S., Pfaff D.W., Agmo A. The role of the estrogen receptor alpha in the medial preoptic area in sexual incentive motivation, proceptivity and receptivity, anxiety, and wheel running in female rats. Behav. Brain Res. 2012, 230:11-20.
404. Steckelbroeck S., Jin Y., Gopishetty S., Oyesanmi B., Penning T.M. Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action. J. Biol. Chem. 2004, 279:10784-10795.
405. Stenoien D.L., Mancini M.G., Patel K., Allegretto E.A., Smith C.L., Mancini M.A. Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol. Endocrinol. 2000, 14:518-534.
406. Strohle A., Holsboer F. Stress responsive neurohormones in depression and anxiety. Pharmacopsychiatry 2003, 36(Suppl. 3):S207-S214.
407. Sutanto W., De Kloet E.R. Species-specificity of corticosteroid receptors in hamster and rat brains. Endocrinology 1987, 121:1405-1411.
408. Suzuki S., Handa R.J. Regulation of estrogen receptor-beta expression in the female rat hypothalamus: differential effects of dexamethasone and estradiol. Endocrinology 2004, 145:3658-3670.
409. Suzuki S., Handa R.J. Estrogen receptor-beta, but not estrogen receptor-alpha, is expressed in prolactin neurons of the female rat paraventricular and supraoptic nuclei: comparison with other neuropeptides. J. Comp. Neurol. 2005, 484:28-42.
410. Sex differences in the Hypothalamo-Pituitary-Adrenal Axis: Novel Roles for Androgen and Estrogen Receptors 2001, Transworld Research Network, Trivandrum. S. Suzuki, T.D. Lund, R.H. Price, R.J. Handa (Eds.).
411. Suzuki S., Solberg L.C., Redei E.E., Handa R.J. Prepro-thyrotropin releasing hormone 178-199 immunoreactivity is altered in the hypothalamus of the Wistar-Kyoto strain of rat. Brain Res. 2001, 913:224-233.
412. Swanson L.W. Immunohistochemical evidence for a neurophysin-containing autonomic pathway arising in the paraventricular nucleus of the hypothalamus. Brain Res. 1977, 128:346-353.
413. Swanson L.W., Kuypers H.G. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J. Comp. Neurol. 1980, 194:555-570.
414. Swanson L.W., Petrovich G.D. What is the amygdala?. Trends Neurosci. 1998, 21:323-331.
415. Swanson L.W., Sawchenko P.E. Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. Annu. Rev. Neurosci. 1983, 6:269-324.
416. Swanson L.W., Sawchenko P.E., Lind R.W. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog. Brain Res. 1986, 68:169-190.
417. Szafarczyk A., Ixart G., Alonso G., Malaval F., Nouguier-Soule J., Assenmacher I. CNS control of the circadian adrenocortical rhythm. J. Steroid Biochem. 1983, 19:1009-1015.
418. Szafarczyk A., Malaval F., Laurent A., Gibaud R., Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology 1987, 121:883-892.
419. Szego C.M., Davis J.S. Adenosine 3',5'-monophosphate in rat uterus: acute elevation by estrogen. Proc. Natl. Acad. Sci. USA 1967, 58:1711-1718.
420. Tabori N.E., Stewart L.S., Znamensky V., Romeo R.D., Alves S.E., McEwen B.S., Milner T.A. Ultrastructural evidence that androgen receptors are located at extranuclear sites in the rat hippocampal formation. Neuroscience 2005, 130:151-163.
421. Tasker J.G., Herman J.P. Mechanisms of rapid glucocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 2011, 14:398-406.
422. Tauchi M., Zhang R., D'Alessio D.A., Stern J.E., Herman J.P. Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei. J. Chem. Neuroanat. 2008, 36:144-149.
423. Terrazzino S., Perego C., De Simoni M.G. Effect of development of habituation to restraint stress on hypothalamic noradrenaline release and adrenocorticotropin secretion. J. Neurochem. 1995, 65:263-267.
424. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
425. Tobet S.A., Handa R.J., Goldstein J.M. Sex-dependent pathophysiology as predictors of comorbidity of major depressive disorder and cardiovascular disease. Pflugers Arch. 2013.
426. Torn S., Nokelainen P., Kurkela R., Pulkka A., Menjivar M., Ghosh S., Coca-Prados M., Peltoketo H., Isomaa V., Vihko P. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem. Biophys. Res. Commun. 2003, 305:37-45.
427. Toufexis D.J., Wilson M.E. Dihydrotestosterone differentially modulates the cortisol response of the hypothalamic-pituitary-adrenal axis in male and female rhesus macaques, and restores circadian secretion of cortisol in females. Brain Res. 2012, 1429:43-51.
428. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53:865-871.
429. Tyagi R.K., Lavrovsky Y., Ahn S.C., Song C.S., Chatterjee B., Roy A.K. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells. Mol. Endocrinol. 2000, 14:1162-1174.
430. Uht R.M., McKelvy J.F., Harrison R.W., Bohn M.C. Demonstration of glucocorticoid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus. J. Neurosci. Res. 1988, 19:405-411. 468-469.
431. Ulrich-Lai Y.M., Engeland W.C. Adrenal splanchnic innervation modulates adrenal cortical responses to dehydration stress in rats. Neuroendocrinology 2002, 76:79-92.
432. Vaccari C., Lolait S.J., Ostrowski N.L. Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain. Endocrinology 1998, 139:5015-5033.
433. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
434. Vamvakopoulos N.C., Chrousos G.P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune/inflammatory reaction. J. Clin. Invest. 1993, 92:1896-1902.
435. Van de Kar L.D., Blair M.L. Forebrain pathways mediating stress-induced hormone secretion. Front. Neuroendocrinol. 1999, 20:1-48.
436. van den Pol A.N. The magnocellular and parvocellular paraventricular nucleus of rat: intrinsic organization. J. Comp. Neurol. 1982, 206:317-345.
437. van Eekelen J.A., Rots N.Y., Sutanto W., Oitzl M.S., de Kloet E.R. Brain corticosteroid receptor gene expression and neuroendocrine dynamics during aging. J. Steroid Biochem. Mol. Biol. 1991, 40:679-683.
438. Van Haarst A.D., Oitzl M.S., de Kloet E.R. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus. Neurochem. Res. 1997, 22:1323-1328.
439. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
440. van Steensel B., van Binnendijk E.P., Hornsby C.D., van der Voort H.T., Krozowski Z.S., de Kloet E.R., van Driel R. Partial colocalization of glucocorticoid and mineralocorticoid receptors in discrete compartments in nuclei of rat hippocampus neurons. J. Cell Sci. 1996, 109(Pt. 4):787-792.
441. Vandesande F., Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat. Cell Tissue Res. 1975, 164:153-162.
442. Vasudevan N., Pfaff D.W. Non-genomic actions of estrogens and their interaction with genomic actions in the brain. Front. Neuroendocrinol. 2008, 29:238-257.
443. Vasudevan N., Kow L.M., Pfaff D.W. Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc. Natl. Acad. Sci. USA 2001, 98:12267-12271.
444. Viau V. Functional cross-talk between the hypothalamic-pituitary-gonadal and -adrenal axes. J. Neuroendocrinol. 2002, 14:506-513.
445. Viau V., Meaney M.J. Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat. Endocrinology 1991, 129:2503-2511.
446. Viau V., Meaney M.J. The inhibitory effect of testosterone on hypothalamic-pituitary-adrenal responses to stress is mediated by the medial preoptic area. J. Neurosci. 1996, 16:1866-1876.
447. Viau V., Meaney M.J. Testosterone-dependent variations in plasma and intrapituitary corticosteroid binding globulin and stress hypothalamic-pituitary-adrenal activity in the male rat. J. Endocrinol. 2004, 181:223-231.
448. Viau V., Soriano L., Dallman M.F. Androgens alter corticotropin releasing hormone and arginine vasopressin mRNA within forebrain sites known to regulate activity in the hypothalamic-pituitary-adrenal axis. J. Neuroendocrinol. 2001, 13:442-452.
449. Viau V., Bingham B., Davis J., Lee P., Wong M. Gender and puberty interact on the stress-induced activation of parvocellular neurosecretory neurons and corticotropin-releasing hormone messenger ribonucleic acid expression in the rat. Endocrinology 2005, 146:137-146.
450. Vrang N., Larsen P.J., Clausen J.T., Kristensen P. Neurochemical characterization of hypothalamic cocaine-amphetamine-regulated transcript neurons. J. Neurosci. 1999, 19:RC5.
451. Waite E.J., McKenna M., Kershaw Y., Walker J.J., Cho K., Piggins H.D., Lightman S.L. Ultradian corticosterone secretion is maintained in the absence of circadian cues. Eur. J. Neurosci. 2012, 36:3142-3150.
452. Walaas I., Fonnum F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience 1980, 5:1691-1698.
453. Walf A.A., Frye C.A. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 2005, 30:1598-1609.
454. Walf A.A., Frye C.A. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol. Biochem. Behav. 2006.
455. Walker Q.D., Francis R., Cabassa J., Kuhn C.M. Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo-pituitary-adrenal axis by cocaine. J. Pharmacol. Exp. Ther. 2001, 297:291-298.
456. Walker J.J., Spiga F., Waite E., Zhao Z., Kershaw Y., Terry J.R., Lightman S.L. The origin of glucocorticoid hormone oscillations. PLoS Biol. 2012, 10:e1001341.
457. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., Mennerick S. 3beta-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 2002, 22:3366-3375.
458. Wei Q., Lu X.Y., Liu L., Schafer G., Shieh K.R., Burke S., Robinson T.E., Watson S.J., Seasholtz A.F., Akil H. Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability. Proc. Natl. Acad. Sci. USA 2004, 101:11851-11856.
459. Weihua Z., Lathe R., Warner M., Gustafsson J.A. An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc. Natl. Acad. Sci. USA 2002, 99:13589-13594.
460. Weiser M.J., Handa R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159:883-895.
461. Weiser M.J., Goel N., Sandau U.S., Bale T.L., Handa R.J. Androgen regulation of corticotropin-releasing hormone receptor 2 (CRHR2) mRNA expression and receptor binding in the rat brain. Exp. Neurol. 2008.
462. Weiser M.J., Wu T.J., Handa R.J. Estrogen receptor-beta agonist diarylpropionitrile: biological activities of R- and S-enantiomers on behavior and hormonal response to stress. Endocrinology 2009, 150:1817-1825.
463. Weissman M.M., Bland R., Joyce P.R., Newman S., Wells J.E., Wittchen H.U. Sex differences in rates of depression: cross-national perspectives. J. Affect. Disord. 1993, 29:77-84.
464. Westphal U. Steroid-protein interactions. Monogr. Endocrinol. 1971, 4:1-567.
465. Westphal U. Corticosteroid-binding globulin. A review of some recent aspects. Mol. Cell. Biochem. 1983, 55:145-157.
466. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 1993, 40:573-629.
467. Whitnall M.H., Gainer H. Major pro-vasopressin-expressing and pro-vasopressin-deficient subpopulations of corticotropin-releasing hormone neurons in normal rats. Differential distributions within the paraventricular nucleus. Neuroendocrinology 1988, 47:176-180.
468. Whitnall M.H., Kiss A., Aguilera G. Contrasting effects of central alpha-1-adrenoreceptor activation on stress-responsive and stress-nonresponsive subpopulations of corticotropin-releasing hormone neurosecretory cells in the rat. Neuroendocrinology 1993, 58:42-48.
469. Williamson M., Viau V. Androgen receptor expressing neurons that project to the paraventricular nucleus of the hypothalamus in the male rat. J. Comp. Neurol. 2007, 503:717-740.
470. Williamson M., Viau V. Selective contributions of the medial preoptic nucleus to testosterone-dependant regulation of the paraventricular nucleus of the hypothalamus and the HPA axis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R1020-R1030.
471. Windle R.J., Shanks N., Lightman S.L., Ingram C.D. Central oxytocin administration reduces stress-induced corticosterone release and anxiety behavior in rats. Endocrinology 1997, 138:2829-2834.
472. Windle R.J., Kershaw Y.M., Shanks N., Wood S.A., Lightman S.L., Ingram C.D. Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J. Neurosci. 2004, 24:2974-2982.
473. Windle R.J., Gamble L.E., Kershaw Y.M., Wood S.A., Lightman S.L., Ingram C.D. Gonadal steroid modulation of stress-induced hypothalamo-pituitary-adrenal activity and anxiety behavior: role of central oxytocin. Endocrinology 2006, 147:2423-2431.
474. 2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135:59-72.
475. Wu W.F., Tan X.J., Dai Y.B., Krishnan V., Warner M., Gustafsson J.A. Targeting estrogen receptor beta in microglia and T cells to treat experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2013, 110:3543-3548.
476. Young L.J., Wang Z., Donaldson R., Rissman E.F. Estrogen receptor alpha is essential for induction of oxytocin receptor by estrogen. NeuroReport 1998, 9:933-936.
477. Young E.A., Altemus M., Parkison V., Shastry S. Effects of estrogen antagonists and agonists on the ACTH response to restraint stress in female rats. Neuropsychopharmacology 2001, 25:881-891.
478. Zhang Y., Damjanoska K.J., Carrasco G.A., Dudas B., D'Souza D.N., Tetzlaff J., Garcia F., Hanley N.R., Scripathirathan K., Petersen B.R., Gray T.S., Battaglia G., Muma N.A., Van de Kar L.D. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. J. Neurosci. 2002, 22:9635-9642.
479. Zhang Z., Cerghet M., Mullins C., Williamson M., Bessert D., Skoff R. Comparison of in vivo and in vitro subcellular localization of estrogen receptors alpha and beta in oligodendrocytes. J. Neurochem. 2004, 89:674-684.
480. Zhang R., Packard B.A., Tauchi M., D'Alessio D.A., Herman J.P. Glucocorticoid regulation of preproglucagon transcription and RNA stability during stress. Proc. Natl. Acad. Sci. USA 2009, 106:5913-5918.
481. Ziegler D.R., Herman J.P. Local integration of glutamate signaling in the hypothalamic paraventricular region: regulation of glucocorticoid stress responses. Endocrinology 2000, 141:4801-4804.
482. Zuloaga D.G., Morris J.A., Jordan C.L., Breedlove S.M. Mice with the testicular feminization mutation demonstrate a role for androgen receptors in the regulation of anxiety-related behaviors and the hypothalamic-pituitary-adrenal axis. Horm. Behav. 2008.